|Bid||43.36 x 1400|
|Ask||43.36 x 1100|
|Day's Range||42.92 - 43.99|
|52 Week Range||38.20 - 49.91|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||0.96 (2.20%)|
|Ex-Dividend Date||Sep 02, 2021|
|1y Target Est||51.00|
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Perrigo (PRGO) offers to acquire HRA Pharma with several leading OTC brands in its portfolio for almost $2.1 billion. The acquisition will complete Perrigo's transformation into a leading self-care company.
Perrigo Company plc (NYSE: PRGO) shares are trading higher after the company announced it will acquire HRA Pharma for $2.1 billion in cash. "The acquisition of HRA would be the crowning achievement in that transformation. With the addition of HRA and its talented leadership team, Perrigo would be a consumer self-care global leader that is poised to deliver top tier net sales growth and double-digit EPS growth in the near-term while concurrently expanding margins," said Murray S. Kessler, CEO and